|
|
Post by theshiv on Dec 27, 2018 1:23:06 GMT -5
The lights are still on and the doors remain unlocked at MNKD and that is enough equity for me. This company was on life support following the Sanofi debacle and Mike and the team should get credit for keeping this company alive despite the death spiral prediction. I acknowledge the current condition is not what drove us to this investment, we all hoped for much more. This story still remains unfinished. Only Mike knows what is under the cards and I'm ok with that.
|
|
|
|
Post by mytakeonit on Dec 27, 2018 2:12:34 GMT -5
Yes, I agree completely. So stick it to the shorts ... ahhh ... theshiv
|
|
|
|
Post by boytroy88 on Dec 27, 2018 5:53:41 GMT -5
The notion that Mike "knows more" has been my mantra on this board for some time and I agree he has done a good job thus far. Yes, everyone here can voice their opinion, but the tone and near histerics here and on other social media platforms in recent days has been surprising. Has he not earned a little equity within our ranks? I don't see Mike letting this asset which we all view as valuable die on the vine. I beleive the man has a plan. We’re currently about 35 cents off the all time low, share count is at highest, and we’re all sitting here wondering what MNKD management is thinking with this offering dropped on us a few days before Christmas. You tell me what equity he has earned with us. If you don't believe in him then maybe it is better for you to cut loose now while you are still 35 cents "ahead". |
|
|
|
Post by winner on Dec 27, 2018 6:50:31 GMT -5
akemp3000
For what it's worth, I agree 100% with what you stated in your recent post.
Like many others on this forum, my blue chip investments have taken a significant hit. I will have to wait for the markets to recover before buying additional MNKD shares. Rest assured, if extrememly positive news was to present itself, I will use cash to buy X number of thousands of shares.
Best of luck to one and all. Hopefully 2019 will be MNKD's year to shine.
|
|
|
|
Post by akemp3000 on Dec 27, 2018 7:46:33 GMT -5
During this challenging end-of-year, low pps moment in time, it may be good to focus on some of the many good things that Michael Castagna has done in the past year and a half; 1)Improved the balance sheet, 2) Reduced debt, 3) Replaced the sales force, 4) Created a pipeline of relationships, 5) Replaced the prior business plan, 6) Hired Dr. Kendall and other quality execs, 7) Expanded to more countries, 8) Partnered with United Technologies, 9) Began DTC TV ads, 10) Growing Afrezza revenue, and much more. It's fine to bash the current pps and recent stock sale even with limited information, but doing so seems to be getting lost in the weeds while the big picture continues to improve. GLTA
|
|
|
|
Post by rockstarrick on Dec 27, 2018 8:12:08 GMT -5
How do you explain the shareprice going from around $3 to $8+ in a matter of hours with positive p3 trial results, (pre approval).
And now we have an FDA approved drug delivery device, the best Mealtime Insulin known to man, and a partnership with United that includes not only TrepT, but also 10 million bucks for R&D of another Inhaled Drug, and we sit at a buck ??
Wall Street is in bed with the enemy. Absolutely no other excuse.
So you guys go ahead and keep the blindfolds on and blame Mike, but for me, it’s very clear that WS is making this as hard as humanly possible for Mannkind and Mike. And if it takes dilution to get to cash flow positive, so be it.
I’ll just keep adding, just as I did the other day, for a buck.
And when we finally do hit that cash flow + milestone, I’ll have a front row seat, watching the trapped Greedy shorts squirm as their fortunes disappear and they lose everything.
It’s coming, get some popcorn and enjoy the show.
✌🏻🎸😎
|
|
|
|
Post by hellodolly on Dec 27, 2018 8:25:44 GMT -5
Shhhhh ... I'm still waiting for my money transfer ... AND more so ... getting a ton more at 82 cents !!! Me, too. I should be good by Monday. |
|
|
|
Post by falconquest on Dec 27, 2018 17:57:42 GMT -5
How do you explain the shareprice going from around $3 to $8+ in a matter of hours with positive p3 trial results, (pre approval). And now we have an FDA approved drug delivery device, the best Mealtime Insulin known to man, and a partnership with United that includes not only TrepT, but also 10 million bucks for R&D of another Inhaled Drug, and we sit at a buck ?? Wall Street is in bed with the enemy. Absolutely no other excuse. So you guys go ahead and keep the blindfolds on and blame Mike, but for me, it’s very clear that WS is making this as hard as humanly possible for Mannkind and Mike. And if it takes dilution to get to cash flow positive, so be it. I’ll just keep adding, just as I did the other day, for a buck. And when we finally do hit that cash flow + milestone, I’ll have a front row seat, watching the trapped Greedy shorts squirm as their fortunes disappear and they lose everything. It’s coming, get some popcorn and enjoy the show. ✌🏻🎸😎 No, Wall St. is looking at the fact that the product isn't selling. If Afrezza took off this company would be fine, but if they can't even sell their lead product then..... |
|
|
|
Post by mytakeonit on Dec 27, 2018 18:07:25 GMT -5
Then we sell it to the WORLD ... then come back to the USA ... when people say "Why don't we have Afrezza here?"
|
|
|
|
Post by mango on Dec 27, 2018 20:23:02 GMT -5
I don't understand any of this shelf offering stuff, but my thoughts are this—Mike believes in what he is doing there at MannKind, and I believe in him. He has done a tremendous job as a leader, and continues to successfully steer the transformation of the company.
I really appreciate Mike and his commitment and respect for the company—I have full confidence in Mike. He is learning and growing as a leader, and so far he has done a damn good job.
The decision to push TreT forward over other pipeline candidates was key. It proved to be a remarkable success—and also illustrates Mike is more than capable of making decisions using logic and not emotions. I'm grateful for Mike Castagna and excited about 2019.
Expectations rise, falling to the side. Fate extends a hand.
It seems that most events aren't planned.
|
|
|
|
Post by falconquest on Dec 27, 2018 20:47:50 GMT -5
I don't understand any of this shelf offering stuff, but my thoughts are this—Mike believes in what he is doing there at MannKind, and I believe in him. He has done a tremendous job as a leader, and continues to successfully steer the transformation of the company. I really appreciate Mike and his commitment and respect for the company—I have full confidence in Mike. He is learning and growing as a leader, and so far he has done a damn good job. The decision to push TreT forward over other pipeline candidates was key. It proved to be a remarkable success—and also illustrates Mike is more than capable of making decisions using logic and not emotions. I'm grateful for Mike Castagna and excited about 2019. Expectations rise, falling to the side. Fate extends a hand.
It seems that most events aren't planned.Ok, so let's examine that. I agree, Mike has done lots of good things. However, looking at his success from a different perspective, that being sales of Afrezza and enhancing shareholder value, he has been an abject failure.......up to this point. IF, the steps he has taken leads to greater sales and shareholder value then he ....WILL have done a good job. As an investor it seems to me that enhancing shareholder value ought to be the metric upon which a CEO is measured, but that's only MY position. As an investor, I certainly want a CEO to make the proper decisions but I also expect enhanced shareholder value as a result. To date that has been elusive at Mannkind. |
|
|
|
Post by mango on Dec 27, 2018 21:07:04 GMT -5
I don't understand any of this shelf offering stuff, but my thoughts are this—Mike believes in what he is doing there at MannKind, and I believe in him. He has done a tremendous job as a leader, and continues to successfully steer the transformation of the company. I really appreciate Mike and his commitment and respect for the company—I have full confidence in Mike. He is learning and growing as a leader, and so far he has done a damn good job. The decision to push TreT forward over other pipeline candidates was key. It proved to be a remarkable success—and also illustrates Mike is more than capable of making decisions using logic and not emotions. I'm grateful for Mike Castagna and excited about 2019. Expectations rise, falling to the side. Fate extends a hand.
It seems that most events aren't planned.Ok, so let's examine that. I agree, Mike has done lots of good things. However, looking at his success from a different perspective, that being sales of Afrezza and enhancing shareholder value, he has been an abject failure.......up to this point. IF, the steps he has taken leads to greater sales and shareholder value then he ....WILL have done a good job. As an investor it seems to me that enhancing shareholder value ought to be the metric upon which a CEO is measured, but that's only MY position. As an investor, I certainly want a CEO to make the proper decisions but I also expect enhanced shareholder value as a result. To date that has been elusive at Mannkind. You are free to examine it dude, and I respect your thinking. Change happens in phases. Mike and Team go to war everyday for the company. I don't know, I just know I couldn't have pulled off what Mike has. When I discovered MannKind everything was in the trenches and Al just died. We are literally 100,000,000 miles from where we were then. I just find it pointless to waste energy stressing on the things I cannot control. Slow script growth sits in an obvious box of BS, Mike cannot control TPTB. I can't complain about shareholder value because me making a profit doesn't come before the people with diabetes etc. All good things in all good time. |
|
|
|
Post by falconquest on Dec 27, 2018 21:59:19 GMT -5
Ok, so let's examine that. I agree, Mike has done lots of good things. However, looking at his success from a different perspective, that being sales of Afrezza and enhancing shareholder value, he has been an abject failure.......up to this point. IF, the steps he has taken leads to greater sales and shareholder value then he ....WILL have done a good job. As an investor it seems to me that enhancing shareholder value ought to be the metric upon which a CEO is measured, but that's only MY position. As an investor, I certainly want a CEO to make the proper decisions but I also expect enhanced shareholder value as a result. To date that has been elusive at Mannkind. You are free to examine it dude, and I respect your thinking. Change happens in phases. Mike and Team go to war everyday for the company. I don't know, I just know I couldn't have pulled off what Mike has. When I discovered MannKind everything was in the trenches and Al just died. We are literally 100,000,000 miles from where we were then. I just find it pointless to waste energy stressing on the things I cannot control. Slow script growth sits in an obvious box of BS, Mike cannot control TPTB. I can't complain about shareholder value because me making a profit doesn't come before the people with diabetes etc. All good things in all good time. ....and I certainly appreciate and admire your position when you say making a profit doesn't come before PWD. Change the juxtaposition, if Al's death represents 100,000,000 miles for you, then my position is about 900,000,000 miles from where I started as an INVESTMENT. That word "investment" represents the idea of a return. I would love nothing more than to be philanthropic with my money, but only after I have sufficient funds. I have been watching this story play out since it was $19.00/share.....pre-split! I know many others have as well. I should think that is sufficient time to see a return on our "investment". This concept of "great things are happening" is a well worn story when it comes to a return. By the way, none of us have any control, we have to rely on corporate management for that. |
|
|
|
Post by mango on Dec 27, 2018 22:11:20 GMT -5
You are free to examine it dude, and I respect your thinking. Change happens in phases. Mike and Team go to war everyday for the company. I don't know, I just know I couldn't have pulled off what Mike has. When I discovered MannKind everything was in the trenches and Al just died. We are literally 100,000,000 miles from where we were then. I just find it pointless to waste energy stressing on the things I cannot control. Slow script growth sits in an obvious box of BS, Mike cannot control TPTB. I can't complain about shareholder value because me making a profit doesn't come before the people with diabetes etc. All good things in all good time. ....and I certainly appreciate and admire your position when you say making a profit doesn't come before PWD. Change the juxtaposition, if Al's death represents 100,000,000 miles for you, then my position is about 900,000,000 miles from where I started as an INVESTMENT. That word "investment" represents the idea of a return. I would love nothing more than to be philanthropic with my money, but only after I have sufficient funds. I have been watching this story play out since it was $19.00/share.....pre-split! I know many others have as well. I should think that is sufficient time to see a return on our "investment". This concept of "great things are happening" is a well worn story when it comes to a return. By the way, none of us have any control, we have to rely on corporate management for that. I understand man, and the thing is, I came along when the PPS was under a buck and stayed under $2 for a while. I was kinda broke anyway at the time so I added every chance I could. I don't have a lot of shares compared to everyone else here, but I know what it is like to lose everything and everyone in your life, and money is the last thing I care about. Stock market comes with risks just like walking into a casino to play blackjack does. I don't feel sorry for anyone that risks their money in the stock market and loses it, because that is what gambling is. It's unfortunate but it's the risk. Safer to just bury it out back. And I meant the company is 100M miles from where they were during the time Sanofi trashed us and then Al died and Andrea Leone-Bay and RLS and all that wild story. We are partnered with a heavy weight now dude. Rothblatt is no joke!! |
|
|
|
Post by cretin11 on Dec 27, 2018 23:08:45 GMT -5
Very well said, falconquest. Mango you are relatively new to this investment (and you have great taste in music btw), lots of us here were once as enthusiastic as you are about it. Mike has done some good things for sure, and I ain’t “giving up on MNKD yet” either. But we aren’t 100,000,000 miles ahead of where we were. Some progress has been made, but it seems to have an inverse relationship to share price. Like it or not that’s a key metric. Hopefully 2019 will bring much better traction on scrips and we will look back on these days as the dark times before the dawn.
|
|
